1Hye A, Kerr F, Archer N, et al. Glycogen synthase kinase-3 is increased in white cells early in Alzheimers disease [ J ]. Neurosic Lett, 2005,373 ( 1 ) : 1-4.
2Leroy K, Yihnaz Z, Brion JP, et al. Increased level of active GSK- 3beta in Alzheimer' s disease and accumulation in argyro philic grains and in neurones at different stages of neurofi brillary degeneration [J]. Neuropathol Appl Neorobiol,2006,33(1) :43-55.
3Frame S,Cohen P. GSK3 takes centre stage more than 20 years after its discovery[J]. Biochem J,2001,359:1-16.
4Jope RS,Johnson GV. The glamour and gloom of glycogen synthase kinase3 [ J]. Trends Biochem Sci ,2004,29:95-102.
5Woodgett JR. Molecular cloning and expression of glycogen synthase kinase-3/factor A [ J ]. EMBO J, 1990,9 (8) :243-248.
8Diniz BS,Pinto JA,Jr Forlenza OV. Do CSF total tau,phosphory- lated tau,and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer s disease? A systematic review and meta-analysis of the literature [ J ]. WoAd J Binl Psychiatry, 2008,9 (3) :172-182.
9Strozyk D, Blennow K, White LR, et al. CSF Aβ42 levels correlate with amyloid-neuropathology in a population based autopsy study[ J]. Neurology, 2003,60 ( 4 ) : 652 -656.
10Fagan AM, Mintun MA, Mach RH, et al. Inverse relation between in vivo amyloid imaging load and eerebrospinal fluid Abeta42 in humans[J]. AnnNeurol,2006,59(3):512-519.
3Petersen RC,Clinic M, Rochester MN. Mild cognitive impairment:transition from aging to Alzheimer's disease[J]. Neurobiol Aging,2000.21(1s) :s1.
4Jelic V. Shigeta M, Julin P, et al. Quantitative electroencephalography power and coherence in Alzheimer's disease and mild cognitive impairment[J]. Dementia,1996.7(6):314-323.
5Schuff N,Amend D,Ezekiel F,et al. Changes of hippocampal Nacetylaspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study [J]. Neurology, 1997, 49(6): 1513-1521.
6Gael C,Beatrice D,Vincent de la S,et al. Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment[J]. Neuro Report ,2002,13(15)1939-1943.
7Chantal S,Braun CM,Bouchard RW,et al. Similar ^1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease[J]. Brain Research, 2004,1003(1-2):26- 35.
8Klunk WE,Xu C,Panchalingham K,et al. Quantitative H and P MRS of PCA extracts of postmortem Alzheimer's disease brain[J]. Neurobiol Aging, 1996,17(3),349-357.
